Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Obesity01:24

Obesity

1.3K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.3K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

266
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
266
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

282
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
282
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

182
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
182

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

QTc Interval Prolongation and Associated Drug Therapy in Hospitalized Older Adults.

Journal of the American Geriatrics Society·2026
Same author

Effect of Incretin-Based and Nonpharmacologic Weight Loss on Body Composition : A Systematic Review.

Annals of internal medicine·2026
Same author

Hospital Frailty Risk Score Predicts Long-Term Hospital Readmissions in Very Old Patients with Heart Failure.

Journal of clinical medicine·2026
Same author

European Working Group on Sarcopenia in Older People Algorithm: Step-by-Step Relation With Length of Hospitalization.

Journal of the American Geriatrics Society·2026
Same author

Sarcopenia, obesity, and functional decline: converging mechanisms and emerging diagnostic frontiers.

Experimental gerontology·2025
Same author

Predictive validation of a questionnaire for the assessment of social care needs in hospitalized older adults, the geriatric discharge complexity score: a diagnostic accuracy study.

Aging clinical and experimental research·2025
Same journal

Seeing cachexia clearly: the evolution of body composition and radiological biomarkers in cancer wasting.

Current opinion in clinical nutrition and metabolic care·2026
Same journal

The updated recommendations for medical nutrition in the perioperative period: a focus on early oral intake.

Current opinion in clinical nutrition and metabolic care·2026
Same journal

Pediatric and adolescent nutritional and metabolic assessment in the precision era.

Current opinion in clinical nutrition and metabolic care·2026
Same journal

Nutrition in cirrhosis: bridging guidelines and practice in hepatic disease.

Current opinion in clinical nutrition and metabolic care·2026
Same journal

Metabolic health in a changing world: widening the lens to climate, cities, and place.

Current opinion in clinical nutrition and metabolic care·2026
Same journal

Beyond the scale: a systems-level reframing of obesity and metabolic care.

Current opinion in clinical nutrition and metabolic care·2026
See all related articles

Related Experiment Video

Updated: Feb 2, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.3K

Sarcopenia and obesity.

Mauro Zamboni1,2, Sofia Rubele1,2, Andrea P Rossi1,2

  • 1Geriatric Division, Department of Medicine, University of Verona.

Current Opinion in Clinical Nutrition and Metabolic Care
|November 22, 2018
PubMed
Summary
This summary is machine-generated.

Sarcopenic obesity, a condition of muscle and fat mass mismatch in older adults, lacks a clear definition. Research is advancing understanding of its health impacts and treatment principles.

More Related Videos

Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment
05:18

Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment

Published on: November 22, 2024

1.4K
An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

1.5K

Related Experiment Videos

Last Updated: Feb 2, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.3K
Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment
05:18

Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment

Published on: November 22, 2024

1.4K
An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

1.5K

Area of Science:

  • Gerontology
  • Metabolic Health
  • Body Composition

Background:

  • Increasing obesity prevalence in older adults contributes to sarcopenic obesity.
  • Sarcopenic obesity is defined by a discordance between muscle and fat mass.
  • Current definitions of sarcopenic obesity are debated, complicating clinical application.

Purpose of the Study:

  • To review recent findings on the interplay between adipose tissue and muscle.
  • To examine the health consequences of sarcopenic obesity and dynapenic abdominal obesity.
  • To explore evolving treatment principles for sarcopenic obesity.

Main Methods:

  • Literature review of recent studies.
  • Analysis of pathogenic relationships between adipose tissue and muscle.
  • Examination of health outcomes associated with specific obesity phenotypes.

Main Results:

  • Progress in defining treatment principles for sarcopenic obesity despite definitional ambiguity.
  • Dynapenic abdominal obesity is a phenotype of increasing clinical interest due to its adverse health effects.
  • Pathogenic links between adipose tissue and muscle are increasingly understood.

Conclusions:

  • Further research is required to compare sarcopenic/dynapenic obesity definitions and their relation to adverse outcomes in the elderly.
  • Establishing optimal therapeutic strategies for sarcopenic obesity is a critical next step.
  • Clarifying the relationship between obesity and adverse health outcomes in aging populations is essential.